Key result
Statin myopathy definitions and management remain unvalidated, highlighting the need for neurologist involvement during evaluation.
Why the study?
What are the neuromuscular side effects of statins and how should statin myopathy be defined and managed?
What are the neuromuscular side effects of statins and how should statin myopathy be defined and managed?
Neurologists should be more involved in the evaluation and management of statin intolerance, as current definitions and management strategies for statin myopathy are inadequate.
Answers are grounded in this paper and cite their sources.
Unvalidated statin myopathy definitions warrant clinical caution; leaves open neurologist involvement pending prospective validation studies.
Statins intolerance is mainly due to their side effects on the neuromuscular system (primarily muscle). It has become an important issue because of the major cardiovascular risk reduction of this class of drugs. However, the facts related to these side effects are sometimes under-recognized or controversial. A literature review of the recent developments in the field is given. The clinical definition of statin myopathy and its presentation are not suitable for the myology field. Management and prevention are not validated. More genetic risk factors need to be established. Neurologists should become more involved in statin intolerance evaluation and management.
No takes yet. Share an insight, caveat, or question.
Zohar Argov (2014) conducted a review in Statin intolerance and myopathy. Statins was evaluated. A literature review highlights that the clinical definition, management, and prevention of statin myopathy remain unvalidated, suggesting neurologists should be more involved in patient evaluation.
Synapse has enriched 10 related papers. Consider them for comparative context: